Marksans Pharma Limited

NSEI:MARKSANS Rapporto sulle azioni

Cap. di mercato: ₹140.1b

Marksans Pharma Dividendi e riacquisti

Dividendo criteri di controllo 3/6

Marksans Pharma è una società che paga dividendi con un rendimento attuale pari a 0.19%, ben coperto dagli utili.

Informazioni chiave

0.2%

Rendimento del dividendo

0.05%

Rendimento del riacquisto

Rendimento totale per gli azionisti0.2%
Rendimento futuro dei dividendi1.1%
Crescita dei dividendi5.0%
Prossima data di pagamento dei dividendin/a
Data di stacco del dividendon/a
Dividendo per azione₹0.600
Rapporto di remunerazione9%

Aggiornamenti recenti su dividendi e riacquisti

Recent updates

Is Now The Time To Put Marksans Pharma (NSE:MARKSANS) On Your Watchlist?

Oct 24
Is Now The Time To Put Marksans Pharma (NSE:MARKSANS) On Your Watchlist?

Optimistic Investors Push Marksans Pharma Limited (NSE:MARKSANS) Shares Up 45% But Growth Is Lacking

Sep 21
Optimistic Investors Push Marksans Pharma Limited (NSE:MARKSANS) Shares Up 45% But Growth Is Lacking

Marksans Pharma Limited (NSE:MARKSANS) Stock Rockets 26% But Many Are Still Ignoring The Company

Jul 28
Marksans Pharma Limited (NSE:MARKSANS) Stock Rockets 26% But Many Are Still Ignoring The Company

Solid Earnings May Not Tell The Whole Story For Marksans Pharma (NSE:MARKSANS)

Jun 07
Solid Earnings May Not Tell The Whole Story For Marksans Pharma (NSE:MARKSANS)

Does Marksans Pharma (NSE:MARKSANS) Deserve A Spot On Your Watchlist?

May 31
Does Marksans Pharma (NSE:MARKSANS) Deserve A Spot On Your Watchlist?

Sentiment Still Eluding Marksans Pharma Limited (NSE:MARKSANS)

Feb 16
Sentiment Still Eluding Marksans Pharma Limited (NSE:MARKSANS)

Here's Why Marksans Pharma (NSE:MARKSANS) Has Caught The Eye Of Investors

Jan 26
Here's Why Marksans Pharma (NSE:MARKSANS) Has Caught The Eye Of Investors

We Think Marksans Pharma (NSE:MARKSANS) Can Manage Its Debt With Ease

Dec 02
We Think Marksans Pharma (NSE:MARKSANS) Can Manage Its Debt With Ease

Marksans Pharma (NSE:MARKSANS) Seems To Use Debt Quite Sensibly

Jun 21
Marksans Pharma (NSE:MARKSANS) Seems To Use Debt Quite Sensibly

Robust Earnings May Not Tell The Whole Story For Marksans Pharma (NSE:MARKSANS)

Nov 17
Robust Earnings May Not Tell The Whole Story For Marksans Pharma (NSE:MARKSANS)

This Is The Reason Why We Think Marksans Pharma Limited's (NSE:MARKSANS) CEO Deserves A Bump Up To Their Compensation

Sep 16
This Is The Reason Why We Think Marksans Pharma Limited's (NSE:MARKSANS) CEO Deserves A Bump Up To Their Compensation

Marksans Pharma (NSE:MARKSANS) Is Increasing Its Dividend To ₹0.25

Sep 01
Marksans Pharma (NSE:MARKSANS) Is Increasing Its Dividend To ₹0.25

Marksans Pharma (NSE:MARKSANS) Could Easily Take On More Debt

Jun 14
Marksans Pharma (NSE:MARKSANS) Could Easily Take On More Debt

Is Now The Time To Put Marksans Pharma (NSE:MARKSANS) On Your Watchlist?

May 27
Is Now The Time To Put Marksans Pharma (NSE:MARKSANS) On Your Watchlist?

Is Marksans Pharma (NSE:MARKSANS) A Risky Investment?

Feb 19
Is Marksans Pharma (NSE:MARKSANS) A Risky Investment?

Marksans Pharma Limited's (NSE:MARKSANS) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Feb 04
Marksans Pharma Limited's (NSE:MARKSANS) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Here's Why We Think Marksans Pharma (NSE:MARKSANS) Is Well Worth Watching

Jan 20
Here's Why We Think Marksans Pharma (NSE:MARKSANS) Is Well Worth Watching

Do Institutions Own Marksans Pharma Limited (NSE:MARKSANS) Shares?

Jan 05
Do Institutions Own Marksans Pharma Limited (NSE:MARKSANS) Shares?

Shareholders Are Thrilled That The Marksans Pharma (NSE:MARKSANS) Share Price Increased 250%

Dec 21
Shareholders Are Thrilled That The Marksans Pharma (NSE:MARKSANS) Share Price Increased 250%

What Can We Conclude About Marksans Pharma's (NSE:MARKSANS) CEO Pay?

Dec 06
What Can We Conclude About Marksans Pharma's (NSE:MARKSANS) CEO Pay?

Stabilità e crescita dei pagamenti

Recupero dei dati sui dividendi

Dividendo stabile: I pagamenti dei dividendi di MARKSANS sono stati volatili negli ultimi 10 anni.

Dividendo in crescita: I pagamenti dei dividendi di MARKSANS sono aumentati negli ultimi 10 anni.


Rendimento dei dividendi rispetto al mercato

Marksans Pharma Rendimento dei dividendi rispetto al mercato
Come si colloca il rendimento da dividendo di MARKSANS rispetto al mercato?
SegmentoRendimento dei dividendi
Azienda (MARKSANS)0.2%
Fondo del 25% del mercato (IN)0.3%
Top 25% del mercato (IN)1.1%
Media del settore (Pharmaceuticals)0.7%
Analista previsionale (MARKSANS) (fino a 3 anni)1.1%

Dividendo notevole: Il dividendo di MARKSANS ( 0.19% ) non è degno di nota rispetto al 25% inferiore dei pagatori di dividendi nel mercato Indian ( 0.25% ).

Dividendo elevato: Il dividendo di MARKSANS ( 0.19% ) è basso rispetto al 25% dei maggiori pagatori di dividendi nel mercato Indian ( 1.14%.


Distribuzione degli utili agli azionisti

Copertura degli utili: Grazie al suo basso payout ratio ( 8.7% ), i pagamenti dei dividendi di MARKSANS sono completamente coperti dagli utili.


Pagamenti in contanti agli azionisti

Copertura del flusso di cassa: Grazie al suo ragionevole cash payout ratio ( 52.3% ), i pagamenti dei dividendi di MARKSANS sono coperti dai flussi di cassa.


Scoprire le società che pagano dividendi forti